BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28225420)

  • 1. Committee Opinion No. 690 Summary: Carrier Screening in the Age of Genomic Medicine.
    Obstet Gynecol; 2017 Mar; 129(3):595-596. PubMed ID: 28225420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin Summary, Number 226.
    Obstet Gynecol; 2020 Oct; 136(4):859-867. PubMed ID: 32976375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226.
    ; ;
    Obstet Gynecol; 2020 Oct; 136(4):e48-e69. PubMed ID: 32804883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Committee Opinion No. 691 Summary: Carrier Screening for Genetic Conditions.
    Obstet Gynecol; 2017 Mar; 129(3):597-599. PubMed ID: 28225421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal genetic carrier screening in the genomic age.
    Gregg AR; Edwards JG
    Semin Perinatol; 2018 Aug; 42(5):303-306. PubMed ID: 30241949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier screening for thalassemia and hemoglobinopathies in Canada.
    Langlois S; Ford JC; Chitayat D; ;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Committee Opinion No. 691: Carrier Screening for Genetic Conditions.
    Obstet Gynecol; 2017 Mar; 129(3):e41-e55. PubMed ID: 28225426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Committee Opinion No. 693 Summary: Counseling About Genetic Testing and Communication of Genetic Test Results.
    Obstet Gynecol; 2017 Apr; 129(4):771-772. PubMed ID: 28333813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Committee Opinion No. 693: Counseling About Genetic Testing and Communication of Genetic Test Results.
    Obstet Gynecol; 2017 Apr; 129(4):e96-e101. PubMed ID: 28333821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finding Middle Ground in Constructing a Clinically Useful Expanded Carrier Screening Panel.
    Stevens B; Krstic N; Jones M; Murphy L; Hoskovec J
    Obstet Gynecol; 2017 Aug; 130(2):279-284. PubMed ID: 28697118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counseling for personal health implications identified during reproductive genetic carrier screening.
    Gbur S; Mauney L; Gray KJ; Wilkins-Haug L; Guseh S
    Prenat Diagn; 2021 Oct; 41(11):1460-1466. PubMed ID: 34426984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanded carrier screening for reproductive risk assessment: An evidence-based practice guideline from the National Society of Genetic Counselors.
    Sagaser KG; Malinowski J; Westerfield L; Proffitt J; Hicks MA; Toler TL; Blakemore KJ; Stevens BK; Oakes LM
    J Genet Couns; 2023 Jun; 32(3):540-557. PubMed ID: 36756860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal Diagnosis Procedures and Techniques to Obtain a Diagnostic Fetal Specimen or Tissue: Maternal and Fetal Risks and Benefits.
    Wilson RD; Gagnon A; Audibert F; Campagnolo C; Carroll J;
    J Obstet Gynaecol Can; 2015 Jul; 37(7):656-668. PubMed ID: 26366824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded Carrier Screening.
    Gregg AR
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):103-112. PubMed ID: 29428278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice Bulletin No. 162 Summary: Prenatal Diagnostic Testing for Genetic Disorders.
    Obstet Gynecol; 2016 May; 127(5):976-978. PubMed ID: 27101119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and post-testing counseling considerations for the provision of expanded carrier screening: exploration of European geneticists' views.
    Janssens S; Chokoshvili D; Vears DF; De Paepe A; Borry P
    BMC Med Ethics; 2017 Aug; 18(1):46. PubMed ID: 28764782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.